GENARO développe une innovation majeure en biotechnologie : un procédé de double sécurisation - biologique et numérique - des données génomiques issues du séquençage à haut débit.
Le procédé de GENARO possède de nombreuses applications dans les domaines de la santé, de la recherche bio-industrielle et des sciences de la vie.
GENARO is developing a major innovation in biotechnology: a dual-security process - both biological and digital - for genomic data derived from high-throughput sequencing. GENARO's process has numerous applications in the fields of healthcare, bio-industrial research, and life sciences.
Company Details
- Employees
- 7
- Founded
- 2023
- Address
- 60, Avenue André Roussin, Marseille,provence-Alpes-Côte D'azur 13016,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://genaro.fr
- Keywords
- biotechnologie.
- HQ
- Marseille, Provence-Alpes-Côte d'Azur
Genaro Questions
Genaro's website is https://genaro.fr
Genaro's LinkedIn profile is https://fr.linkedin.com/company/genaro-biotech
Genaro has
7 employees.
View email and phone details for 7
employees at Genaro.
Genaro's industry is
Biotechnology Research
Genaro's top competitors are
Germe S.a.,
Marseille Medical Genetics,
Oncoage,
Neurochlore,
Remedex,
Diogenx,
Vect-Horus,
Neoflow Therapeutics,
Imcheck Therapeutics,
Innate Pharma.
Genaro's categories are Biotechnology Research
Genaro's founding year is 2023
